+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 25Years +
All Genders
ID03972124

Study of Cannabis CBD Capsules as Preventive Treatment for Adults with Chronic Migraine Randomized, Double-Blind, Placebo-Controlled Trial Comparing Two CBD Doses

Led by University of Calgary · Updated on 2026-05-01

72

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the efficacy and safety of cannabis, specifically cannabidiol CBD, for preventing chronic migraine headaches. Chronic migraine is a neurological disorder causing frequent, moderate to severe headaches often with sensory sensitivity and nausea, which can greatly impact daily life. Due to limited effectiveness and side effects of current treatments, this Phase 2 randomized, double-blind, placebo-controlled trial aims to explore cannabis as a new preventive option. Participants will be randomly assigned to one of three groups a lower dose CBD group starting at 10 mg once daily and increasing every 4 days to 100 mg once daily, a higher dose CBD group starting at 10 mg once daily and increasing every 4 days to 200 mg once daily, or a placebo group receiving soft-gel capsules without CBD. The study treatment is given in soft-gel capsules purified to contain less than 1% THC. Dose escalation occurs in the first few weeks to reach target doses. During the study, participants will complete headache diaries and questionnaires to track headache days, intensity, medication use, and quality of life. The primary outcome is the change in the number of headache days comparing a 4-week baseline period to the 4 weeks before the 3-month follow-up. Secondary outcomes include headache frequency and intensity changes up to 6 months, medication use, and scores on disability, anxiety, depression, and sleep quality assessments. Safety and adherence will be monitored throughout the study, which lasts at least 6 months from baseline to follow-up.

CONDITIONS

Brief Title

Cannabis for the Prophylactic Treatment of Migraine

Research Team

C

CHAMP Research (Calgary Headache Assessment & Management Prog)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here